Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Twist Bioscience Corp shares valued at $8,160 were sold by Cho Dennis on Jun 06 ’25. At $31.75 per share, Cho Dennis sold 257 shares. The insider’s holdings dropped to 105,061 shares worth approximately $3.53 million following the completion of this transaction.
Also, Green Paula sold 853 shares, netting a total of over 27,083 in proceeds. Following the sale of shares at $31.75 each, the insider now holds 127,895 shares.
Before that, Leproust Emily M. had sold 2,170 shares from its account. In a trade valued at $68,898, the Chief Executive Officer traded Twist Bioscience Corp shares for $31.75 each. Upon closing the transaction, the insider’s holdings decreased to 2,170 shares, worth approximately $21.77 million.
As published in their initiating research note from Wolfe Research on December 13, 2024, Twist Bioscience Corp [TWST] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 17, 2024, Goldman has increased its “Neutral” rating to a “Buy” for TWST. Earlier on September 27, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for TWST stock.
Analyzing TWST Stock Performance
During the last five days, there has been a surge of approximately 10.88%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -27.63%. Shares of the company reached a 52-week high of $55.33 on 01/24/25 and a 52-week low of $27.12 on 05/23/25.
Support And Resistance Levels for Twist Bioscience Corp (TWST)
According to the 24-hour chart, there is a support level at 33.17, which, if violated, would cause prices to drop to 32.72. In the upper region, resistance lies at 34.45. The next price resistance is at 35.27. RSI (Relative Strength Index) is 54.46 on the 14-day chart, showing neutral technical sentiment.
